FRS2 Monoklonaler Antikörper

FRS2 Monoklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Maus / IgG3

Getestete Reaktivität

human

Anwendung

WB, IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

4E10H12

Kat-Nr. : 66263-1-PBS

Synonyme

SNT, FRS2alpha, FRS2A, FGFR-signaling adaptor SNT, FGFR substrate 2



Geprüfte Anwendungen

Produktinformation

66263-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA FRS2 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG3
Klonalität Monoklonal
Typ Antikörper
Immunogen FRS2 fusion protein Ag19299
Vollständiger Name fibroblast growth factor receptor substrate 2
Berechnetes Molekulargewicht 60 kDa
Beobachtetes Molekulargewicht 68 kDa
GenBank-ZugangsnummerBC021562
Gene symbol FRS2
Gene ID (NCBI) 10818
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Fibroblast growth factor (FGF) receptor substrate 2 (FRS2) has an alternative name as SNT-1, it is an adapter protein that links activated FGR and NGF receptors to downstream signaling pathways. FGF receptor substrates (FRS2 and FRS3) are key adaptor proteins that mediate FGF-FGFR signalling in benign as well as malignant tissue. FRS2 is a 508 amino-acid protein,which is phosphorylated on tyrosine residues. The molecular weight of non-phosphorylated FRS2 is 57-68 kDa, but phosphorylated FRS2 is 80-90 kDa. Phosphorylation of FRS2 is associated with activation of a number of MAP kinases. Allele-specific regulation of FGFR2 mRNA expression with a mildly increased breast cancer risk has been reported.